Free Trial

Assertio (ASRT) Competitors

Assertio logo
$0.79 +0.02 (+2.05%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$0.78 0.00 (-0.61%)
As of 08/22/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ASRT vs. CGC, DMAC, OCGN, DSGN, RNAC, DRUG, NGNE, HUMA, PBYI, and ACB

Should you be buying Assertio stock or one of its competitors? The main competitors of Assertio include Canopy Growth (CGC), DiaMedica Therapeutics (DMAC), Ocugen (OCGN), Design Therapeutics (DSGN), Cartesian Therapeutics (RNAC), Bright Minds Biosciences (DRUG), Neurogene (NGNE), Humacyte (HUMA), Puma Biotechnology (PBYI), and Aurora Cannabis (ACB). These companies are all part of the "pharmaceutical products" industry.

Assertio vs. Its Competitors

Canopy Growth (NASDAQ:CGC) and Assertio (NASDAQ:ASRT) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.

Canopy Growth has a beta of 0.67, indicating that its share price is 33% less volatile than the S&P 500. Comparatively, Assertio has a beta of 0.28, indicating that its share price is 72% less volatile than the S&P 500.

Assertio has a net margin of -36.97% compared to Canopy Growth's net margin of -155.76%. Assertio's return on equity of -38.19% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth-155.76% -89.93% -44.24%
Assertio -36.97%-38.19%-15.45%

Assertio has lower revenue, but higher earnings than Canopy Growth. Assertio is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy Growth$225.65M1.35-$429.86M-$3.03-0.42
Assertio$124.96M0.61-$21.58M-$0.45-1.75

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 49.0% of Assertio shares are held by institutional investors. 0.2% of Canopy Growth shares are held by company insiders. Comparatively, 4.0% of Assertio shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Canopy Growth had 1 more articles in the media than Assertio. MarketBeat recorded 3 mentions for Canopy Growth and 2 mentions for Assertio. Canopy Growth's average media sentiment score of 0.89 beat Assertio's score of 0.00 indicating that Canopy Growth is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Canopy Growth
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Assertio
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Assertio has a consensus price target of $2.38, suggesting a potential upside of 202.24%. Given Assertio's stronger consensus rating and higher probable upside, analysts clearly believe Assertio is more favorable than Canopy Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
2 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.33
Assertio
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Assertio beats Canopy Growth on 10 of the 16 factors compared between the two stocks.

Get Assertio News Delivered to You Automatically

Sign up to receive the latest news and ratings for ASRT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ASRT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ASRT vs. The Competition

MetricAssertioMED IndustryMedical SectorNASDAQ Exchange
Market Cap$75.63M$2.53B$5.81B$9.76B
Dividend YieldN/A1.67%4.39%4.06%
P/E Ratio-1.7522.9031.3626.05
Price / Sales0.61516.56387.8788.42
Price / Cash16.01179.1038.0259.36
Price / Book0.815.939.536.60
Net Income-$21.58M$31.83M$3.26B$265.65M
7 Day Performance-3.36%1.89%2.14%2.00%
1 Month Performance4.84%1.62%3.22%0.46%
1 Year Performance-38.61%9.25%30.18%18.88%

Assertio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ASRT
Assertio
2.0191 of 5 stars
$0.79
+2.1%
$2.38
+202.2%
-38.6%$75.63M$124.96M-1.7520
CGC
Canopy Growth
0.7337 of 5 stars
$1.37
+5.4%
N/A-79.5%$311.80M$225.65M-0.453,150Short Interest ↑
DMAC
DiaMedica Therapeutics
1.5316 of 5 stars
$5.76
-4.5%
$12.33
+114.1%
+52.8%$311.68MN/A-8.3520Short Interest ↑
OCGN
Ocugen
1.0673 of 5 stars
$1.04
-1.0%
$6.00
+476.9%
-22.3%$306.92M$4.05M-5.2080
DSGN
Design Therapeutics
0.1635 of 5 stars
$5.40
+1.3%
N/A+7.6%$303.53MN/A-4.8240
RNAC
Cartesian Therapeutics
2.6079 of 5 stars
$11.28
-0.4%
$40.00
+254.6%
-18.3%$294.60M$38.91M-0.2164Positive News
Gap Up
DRUG
Bright Minds Biosciences
2.6698 of 5 stars
$45.55
+8.9%
$83.25
+82.8%
+4,252.5%$294.58MN/A-48.98N/ATrending News
Analyst Forecast
Analyst Revision
NGNE
Neurogene
1.7182 of 5 stars
$20.45
-0.3%
$46.17
+125.8%
-42.8%$292.72M$930K-4.7490
HUMA
Humacyte
2.3384 of 5 stars
$1.80
-4.3%
$10.64
+491.3%
-77.5%$291.62M$1.57M-4.00150Insider Trade
Gap Down
PBYI
Puma Biotechnology
4.0836 of 5 stars
$5.01
-12.6%
$7.00
+39.7%
+106.7%$288.63M$238.06M5.11200High Trading Volume
ACB
Aurora Cannabis
0.8031 of 5 stars
$5.12
+0.8%
N/A-23.3%$286.79M$246.72M-26.951,130

Related Companies and Tools


This page (NASDAQ:ASRT) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners